Gelsolin Is Associated with Longer Metastasis-free Survival and Reduced Cell Migration in Estrogen Receptor-positive Breast Cancer.

MLA

Stock, Anna-Maria, et al. “Gelsolin Is Associated with Longer Metastasis-Free Survival and Reduced Cell Migration in Estrogen Receptor-Positive Breast Cancer.” Anticancer Research, vol. 35, no. 10, Oct. 2015, pp. 5277–85. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=26408687&authtype=sso&custid=ns315887.

APA

Stock, A.-M., Klee, F., Edlund, K., Grinberg, M., Hammad, S., Marchan, R., Cadenas, C., Niggemann, B., Zänker, K. S., Rahnenführer, J., Schmidt, M., Hengstler, J. G., & Entschladen, F. (2015). Gelsolin Is Associated with Longer Metastasis-free Survival and Reduced Cell Migration in Estrogen Receptor-positive Breast Cancer. Anticancer Research, 35(10), 5277–5285.

Chicago

Stock, Anna-Maria, Franziska Klee, Karolina Edlund, Marianna Grinberg, Seddik Hammad, Rosemarie Marchan, Cristina Cadenas, et al. 2015. “Gelsolin Is Associated with Longer Metastasis-Free Survival and Reduced Cell Migration in Estrogen Receptor-Positive Breast Cancer.” Anticancer Research 35 (10): 5277–85. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=26408687&authtype=sso&custid=ns315887.